Related Experiment Video
Updated: Jun 26, 2025

Establishing 3D Endometrial Organoids from the Mouse Uterus
Published on: January 6, 2023
Decreased expression of KLF6 in ectopic endometrial stromal cells contributes to endometriosis progression by
Jingwen Shi1, Wenda Jing1, Yueyun He1
1Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang 110004, PR China.
Abstract:
Despite decades of research, endometriosis remains a mysterious gynecological disease with unknown etiology and pathogenesis. Krüppel-like Factor 6 (KLF6), a transcription factor, has a wide expression profile and regulates a variety of biological processes. Here, we investigated the expression and function of KLF6 and its possible regulatory mechanisms in endometriosis. To determine the function of KLF6, knockdown and overexpression experiments were performed in eutopic endometrial stromal cells (EU-ESCs) and ectopic endometrial stromal cells (EC-ESCs), respectively. Cell viability, apoptosis, migration, invasion, and angiogenesis assays were conducted in ESCs. ChIP-sequencing and mRNA-sequencing were performed to investigate the functional mechanism of KLF6 in regulating ESCs. We found that KLF6 was highly expressed in eutopic endometrium of endometriosis patients, compared with ectopic endometrium. Similarly, the same was true in EU-ESCs, which was compared with EC-ESCs. Overexpression of KLF6 significantly suppressed EC-ESC proliferation, migration and invasion and induced cell apoptosis, while knockdown of KLF6 resulted in the opposite effects on EU-ESCs. Overexpression of KLF6 significantly inhibited EC-ESC angiogenesis. Mechanistically, the results of ChIP sequencing and mRNA sequencing revealed that CTNNB1 may be a transcriptional target regulated by KLF6. Reintroduction of KLF6 reversed the effects of KLF6 knockdown on EU-ESCs. KLF6 inhibited the proliferation, migration and angiogenesis of EC-ESCs by inhibiting the expression of CTNNB1. Our findings provided a new perspective on the role of KLF6 in endometriosis progression and inspire potential targeted therapeutic strategies.
Insights
Krüppel-like Factor 6 (KLF6) is highly expressed in endometriosis and inhibits cell proliferation, migration, and angiogenesis. KLF6 targets CTNNB1, offering potential therapeutic strategies for this gynecological disease.
Area of Science:
- Gynecology
- Molecular Biology
- Cell Biology
Background:
- Endometriosis is a poorly understood gynecological disease.
- Krüppel-like Factor 6 (KLF6) is a transcription factor with diverse regulatory roles.
- The role of KLF6 in endometriosis pathogenesis is unclear.
Purpose of the Study:
- To investigate the expression and function of KLF6 in endometriosis.
- To elucidate the regulatory mechanisms of KLF6 in endometrial stromal cells (ESCs).
- To explore KLF6 as a potential therapeutic target for endometriosis.
Main Methods:
- Knockdown and overexpression of KLF6 in eutopic (EU-ESCs) and ectopic (EC-ESCs) endometrial stromal cells.
- Assays for cell viability, apoptosis, migration, invasion, and angiogenesis.
- ChIP-sequencing and mRNA-sequencing to identify KLF6 targets.
Main Results:
- KLF6 expression is elevated in the eutopic endometrium and EU-ESCs of endometriosis patients.
- KLF6 overexpression suppressed EC-ESC proliferation, migration, invasion, and angiogenesis, while inducing apoptosis.
- KLF6 knockdown in EU-ESCs had opposite effects.
- KLF6 was found to transcriptionally regulate CTNNB1, inhibiting its expression.
Conclusions:
- KLF6 plays a significant role in endometriosis progression.
- KLF6 inhibits ESC proliferation, migration, and angiogenesis by targeting CTNNB1.
- KLF6 represents a promising therapeutic target for endometriosis.
Related Concept Videos
The Tumor Microenvironment
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

